Kentaro Takeda

29PUBLICATIONS
21CO-AUTHORS
ChemotherapyRadiation therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jul 07, 2026
A Bayesian Optimal Interval Design Considering Efficacy and Toxicity in Early Phase Basket Trials.

|Apr 19, 2026
A Seamless Two-Stage Phase I/II Trial Design With Backfill and Joint Monitoring for Dose Optimization.

|Mar 29, 2026
A Constrained Hierarchical Bayesian Model Considering Latent Biomarker Subgroups for Time-To-Event Endpoints in Randomized Phase II Trials.

Yifei Huang, Kentaro Takeda, Yongyun Zhao

|Dec 22, 2025
Multi-armed bandits backfill Bayesian optimal interval design.

Masahiro Kojima, Kentaro Takeda

|Nov 17, 2025
Statistical Consideration for Event-Free Survival With Cure Rate in Acute Myeloid Leukemia Studies.

Yuichiro Kaneko, Kentaro Takeda, Shufang Liu

|Oct 17, 2025
BOIN-MEM: A Two-Stage Design for Dose Optimization With Information Borrowing Across Dose Levels and Stages in Oncology Phase I/II Trials.

Ryo Kitabayashi, Kentaro Takeda, Hiroyuki Sato

Pageof 5

Frequent Collaborators

4 joint publications

Yusuke Yamaguchi

2 joint publications

Tomoyuki Kakizume

2 joint publications

Ying Yuan

2 joint publications

Akihiro Hirakawa